Q2 2025 Holdings
Filed 2025-08-11 | 24 holdings | $132.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $27.4M | 7,609,812 | 20.7% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $20.8M | 3,824,417 | 15.7% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $20.2M | 14,250,000 | 15.3% |
| Instil BIO Inc(TIL) | COM NEW | 45783C200 | $11.1M | 534,899 | 8.4% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $7.2M | 4,221,546 | 5.4% |
| Oramed Pharmaceuticals Inc(ORMP) | COM NEW | 68403P203 | $6.9M | 3,083,253 | 5.2% |
| Adverum Biotechnologies Inc(AVU0) | COM NEW | 00773U207 | $6.6M | 3,057,526 | 5.0% |
| Ikena Oncology Inc | COM | 45175G108 | $5.4M | 4,030,102 | 4.1% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $5.3M | 5,000,000 | 4.0% |
| Alumis Inc(ALMS) | COM | 022307102 | $3.6M | 1,210,415 | 2.7% |
| Kezar Life Sciences Inc(KZR) | COM NEW | 49372L209 | $2.9M | 635,183 | 2.2% |
| Lava Therapeutics NV | SHS | N51517105 | $2.6M | 1,970,610 | 2.0% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $2.2M | 1,136,091 | 1.7% |
| Elevation Oncology Inc | COM | 28623U101 | $2.2M | 5,890,434 | 1.6% |
| Connect Biopharma Hldgs LTD | ADS | 207523101 | $1.8M | 1,821,558 | 1.4% |
| Tesla Inc(TSLA)Put | COM | 88160R101 | $1.7M | 200 | 1.3% |
| Astrotech Corp(ASTC) | COM | 046484309 | $1.3M | 220,410 | 1.0% |
| Athira Pharma Inc | COM | 04746L104 | $975.7K | 3,230,667 | 0.7% |
| Lisata Therapeutics Inc(LSTA) | COM | 128058302 | $608.3K | 209,814 | 0.5% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $475.1K | 118,766 | 0.4% |
| Turnstone Biologics Corp | COM | 90042W100 | $396.1K | 1,103,386 | 0.3% |
| Vistagen Therapeutics Inc(VTGN) | COM | 92840H400 | $300.0K | 150,000 | 0.2% |
| Hillevax Inc | COM | 43157M102 | $182.9K | 91,913 | 0.1% |
| Verrica Pharmaceuticals Inc | COM | 92511W108 | $92.6K | 174,651 | 0.1% |